Toronto-based Biossil secures $70 million in funding to revive failed medicines, led by OpenAI and Founders Fund.
Amount Raised
$70 Million
Round Type
Funding Round
Investors
Description
Biossil has exited stealth mode with $70 million raised to utilize AI in reviving discarded drug candidates. The funding round includes high-profile investors like OpenAI and Founders Fund. The biotech startup aims to become a leading player in the pharmaceutical industry by focusing on underutilized molecules. Co-founder Anthony Mouchantaf emphasizes the potential of AI in healthcare.
Quick answer
Biossil raised $70 Million in a Funding Round round, dated April 23, 2026. Investors: Dri Healthcare, 137 Ventures, Quiet Capital, Panache Ventures, Modern Capital, Staircase Ventures, Golden Ventures and OpenAI.
- How much did Biossil raise?
- Biossil raised $70 Million in a Funding Round round on April 23, 2026.
- Who invested in Biossil?
- Dri Healthcare, 137 Ventures, Quiet Capital, Panache Ventures, Modern Capital, Staircase Ventures, Golden Ventures and OpenAI are named as investors in this round.
- What does Biossil do?
- Biossil is a Toronto-based biotech startup that connects AI with drug development by identifying molecules that could succeed where others failed in clinical trials.
- Where is Biossil based and how big is it?
- Fundz records about 5 employees.
- Who are the decision-makers at Biossil?
- Fundz holds 1 contact at Biossil, including the Head of Regulatory. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Pharmaceutical and Biotechnology around the same time
Companies in the same sectors as Biossil that raised within 45 days of this round, from Fundz verified event records.
- Ingenix raised $15M (Seed) on June 3, 2026.
- Perceptic raised $12M (Seed) on May 26, 2026.
- Helical raised $10M (Seed) on April 14, 2026.
- Voyageur Pharmaceuticals raised $316K (Seed) on June 5, 2026.
- Flourish raised $500M (Funding Round) on June 5, 2026.
- Lila Sciences raised $350M (Series A) on June 4, 2026.
Who to call at Biossil, and when
A new round usually means Biossil is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Biossil raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Biossil, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Biossil. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Biossil raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Biossil raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.